Work

Venetoclax Plus Rituximab can Achieve Durable Treatment-Free Remission in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

Year: 2016

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2016.07.073

Authors: Michael Choi, Danielle Brander, Andrew W. Roberts, John F. Seymour, Thomas J. Kipps, Jacqueline C. Barrientos, Matthew S. Davids, Mary Ann Anderson, Constantine Tam, Betty Prine, Carmen Cornejo, Ming Zhu, Leanne Lash, Su Young Kim, Shuo Ma

Institutions: University of California San Diego, Duke Medical Center, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, Peter MacCallum Cancer Centre, Hofstra University, Dana-Farber Cancer Institute, AbbVie (United States), Northwestern University

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2522802085

FWCI:

Cites:

Cited by:

Related to: 10